Efficacy and Pharmacodynamic Target Attainment for Ceftazidime–Avibactam Off-Label Dose Regimens in Patients with Continuous or Intermittent Venovenous Hemodialysis: Two Case Reports

Limited data are available for ceftazidime–avibactam (CZA) dosing in patients receiving renal replacement therapy, especially the data on the dosing in patients receiving intermittent hemodialysis (IHD). In this report, we firstly described a case in which CZA was administered as 2.5 g after each ti...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiao-Shan, Wang, Yu-Zhen, Shi, Da-Wei, Xu, Fang-Min, Yu, Jun-Hui, Chen, Jie, Lin, Guan-Yang, Zhang, Chun-Hong, Yu, Xu-Ben, Tang, Cong-Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669261/
https://www.ncbi.nlm.nih.gov/pubmed/35394640
http://dx.doi.org/10.1007/s40121-022-00621-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669261/
https://www.ncbi.nlm.nih.gov/pubmed/35394640
http://dx.doi.org/10.1007/s40121-022-00621-z

Ejemplares similares